2020 ACCP Webinar February | Communicating Your Science: From Blank Screen to Published Article for Students, Trainees, and Early-Stage Professionals (and a refresher for everybody else)-LIVE
ACCP 2020 Webinar - Communicating Your Science: From Blank Screen to Published Article for Students, Trainees, and Early-Stage Professionals (and a refresher for everybody else)
Live webinar: February 3, 2020
On-demand webinar recording: February 3, 2020 to February 3, 2023
Why is this article important to your practice?
At the completion of this webinar participants will expand their skill set to publish scientific manuscripts and expand written communication abilities.
Researchers, Physicians, Pharmacists, and other professionals requiring training in the professional competencies of peer reviewing.
After completing this activity, the learner will be able to:
- Articulate the process and key steps of outlining, drafting, editing and submitting a manuscript to communicate research to the scientific community or within their current;
- Demonstrate their newly gained knowledge of the process of writing, reviewing, editing and revising draft scientific manuscripts in order to improve the likelihood of acceptance and provide a high quality revised manuscript;
- Recognize different manuscript formats (brief reports, short communication, expert opinion, full-length article, and review article) and appropriate supporting documents/supplemental material that are necessary to effectively communicate their scientific research results;
- Deepen their expertise and understanding of the differences between journals and to choose the appropriate journal in order for their research to achieve the best exposure/impact;
- Recognize potential of target journal being a predatory or opportunistic journal.
To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.
Joseph S. Bertino Jr., PharmD, FCP, FCCP
Editor-in-Chief The Journal of Clinical Pharmacology
Dr. Bertino is currently a Principal at Bertino Consulting, located in Schenectady, NY. He is an Associate Professor of Pharmacology at the College of Physicians and Surgeons, Columbia University, New York, NY and an adjunct Associate Professor at the University at Buffalo School of Pharmacy. He is also an Honorary Professor, Hanoi University of Pharmacy and a Distinguished Professor of the Hai Phong University of Medicine and Pharmacy. Dr. Bertino received his B.S.Pharmacy and Pharm.D. degrees from the University at Buffalo in Buffalo, NY, USA. He has published over 100 original research papers, review articles and book chapters and a textbook of pharmacogenomics. His publications have included work in the area of antimicrobial pharmacokinetics, pharmacodynamics and toxicity, drug-drug interactions, general clinical pharmacology, vaccine pharmacology and the application of pharmacogenetics and pharmacogenomics to the drug development process.
He serves on the Editorial Board of The European Journal of Clinical Pharmacology and Antimicrobial Agents and Chemotherapy. Dr. Bertino has served on the Food and Drug Administration’s Antiinfective and Antiviral Advisory Committees. He also serves as the Editor-in-Chief of the Journal of Clinical Pharmacology.
David J. Greenblatt MD, FCP
Professor, Tuffs Univ School of Medicine, Editor-in-Chief, Clinical Pharmacology in Drug Development
Dr. Greenblatt has been on the Faculty of Tufts University School of Medicine and the Staff of Tufts Medical Center since 1979. He holds the Louis Lasagna, M. D., Endowed Professorship at Tufts University School of Medicine, in the Department of Immunology (formerly the Department of Pharmacology and Experimental Therapeutics), and is a senior faculty member in the Graduate Program in Pharmacology & Experimental Therapeutics at the Sackler School of Graduate Biomedical Sciences at Tufts University. He also holds appointments as Professor of Psychiatry, Medicine, and Anesthesia, Tufts University School of Medicine. He has previously served as Chair of the Department of Pharmacology and Experimental Therapeutics at Tufts University School of Medicine, Program Director and Associate Program Director of the institution’s Clinical/Translational Research Center (formerly the General Clinical Research Center), and Chair of the Institutional Review Board. He is Editor-in-Chief of Clinical Pharmacology in Drug Development, operated by the American College of Clinical Pharmacology. He also is Co-Editor-in-Chief, with Dr. Richard I. Shader, of the Journal of Clinical Psychopharmacology,
A native of Newton, Massachusetts, Dr. Greenblatt is a Magna Cum Laude graduate of Amherst College (1966), where he was senior class president and co-captain of the varsity football team. After college he attended Harvard Medical School, graduating in 1970. Thereafter he trained in internal medicine at the Montefiore Hospital, New York City (1970-1971), and on the Harvard Medical Service at Boston City Hospital (1971-1972). Following a Fellowship in Clinical Pharmacology at Massachusetts General Hospital under the mentorship of Dr. Jan Koch-Weser (1972-1974), he stayed on to head the Clinical Pharmacology Unit at Mass. General from 1975 to 1979, at which time he moved to Tufts.
Stephan Schmidt, PhD
Dr. Schmidt is an endowed, tenured Associate Professor at the Univ of Florida’s Ctr for Pharmacometrics & Systems Pharmacology in Lake Nona, Orlando. He currently serves as the Associate Director of the Ctr. His research focuses on the development and application of mechanism-based drug-disease models in the area of antimicrobial chemotherapy, pediatrics, diabetes, cardiovascular safety and post-menopausal osteoporosis. Dr. Schmidt published more than 60 peer-reviewed articles in highly-respected journals in the clinical pharmacology arena as well as four book chapters. He is the lead editor of a book entitled, Applied Pharmacometrics, published in 2014 as part of an AAPS series on advancing pharmaceutical sciences. Dr. Schmidt received the Paul Ehrlich Society for Chemotherapy Thesis Award in 2010, the Univ of Florida Clinical Translational Science Inst Junior Faculty Pilot Program Award in 2012, the Univ of Florida Excellence Award for Assistant Professors in 2013 and the Tanabe Young Investigator Award from the American Coll of Clinical Pharmacology® (ACCP) in 2016. He serves as the Chair of the Special Interest Group on PK/PD and Systems Pharmacology of the Intl Pharmaceutical Federation (FIP) and the is the immediate Past Chair of the Systems Pharmacology Community for the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Dr. Schmidt is a Section Editor for the European Journal of Pharmaceutical Sciences and Editorial Board Member for The Journal of Clinical Pharmacology and ASCPT’s Pharmacometrics and Systems Pharmacology journal.
Matthew B. Dufek, PhD
Dr. Dufek completed his graduate training at the University of North Carolina at Chapel Hill and is currently a Director of Clinical Development at AbbVie Inc in Chicago, IL. For over 20 years, Dr. Dufek has worked at several small biotechnology as well as large pharmaceutical companies. Joining AbbVie in 2012, he currently holds a position as a Director of Clinical Development in the Department of Clinical Pharmacology & Pharmacometrics where he helps lead the clinical pharmacology & clinical development strategy/team for the development of new pharmaceutical therapies as well as supporting a diverse portfolio of marketed products. These projects have included supporting therapeutic areas of pulmonary medicine, immunology, men’s & women’s health, anti-infective (HIV, RSV and HCV), oncology, renal and pediatrics therapies. Dr. Dufek has an interest and has lectured at many conferences throughout the world as a leading expert in the development of novel approaches for pediatric drug development.
Oliver Grundmann, PhD
Clinical Associate Professor, Director, Univ of Florida Coll of Pharmacy, Medical Chemistry
Dr. Grundmann is the Clinical Associate Professor and Director of Graduate Programs in Clinical Toxicology & Pharmaceutical Chemistry at the Coll of Pharmacy, Univ of Florida. His primary research focus is centered on natural products, specifically with CNS activity for depression, anxiety and other mood disorders. Clinical investigations into potential integrative and complementary use of natural products in a variety of best practice settings have provided him with a wide range of collaborative opportunities. Aside from his research interests, Dr. Grundmann is a staunch advocate for interdisciplinary and collaborative teaching in a connected global world allowing him to travel and frequently meet with colleagues and students from all areas of the world. In a sense, both a holistic research and teaching approach. He has been a member of ACCP, a Fellow and serves currently on the Board of Regents. As part of his ongoing research collaborations, he is familiar with the significant efforts involved in writing and publishing a scientific manuscript.